RecruitingNot Applicable

Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients

Egypt70 participantsStarted 2025-01-10

Plain-language summary

The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU discharge.

Who can participate

Age range25 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with acute burn admitted to burn ICU within 24 hours from the burn incidence. * patients with burn percentage of 25% to 50% of total body surface area * patients with second to third degree burns * ASA 1 and ASA 2 patients Exclusion Criteria: * Burn percentage more than 50% or less than 25% of total body surface area * Having autoimmune diseases * Cancer patients * ASA 3 and ASA 4 patients

What they're measuring

Occurrence of sepsis and septic shock

Timeframe: From day 1 to day 10 in burn ICU

Trial details

NCT IDNCT06915974

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-10

Contact for this trial

Ahmed H Elsayed, M.B.B.CH

+201016305451 AhmedHanyAbdelfatah@med.asu.edu.eg

View on ClinicalTrials.gov More Burns trials